Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mathew

Showing results (621-630 of 845) with videos related to

Pageof 85
Sort By:
JAMA Psychiatry|March 2, 2017
A Consensus Statement on the Use of Ketamine in the Treatment of Mood DisordersGerard Sanacora, Mark A Frye, William McDonald, et al.
Journal of Psychopathology and Clinical Science|September 23, 2024
Functional connectivity subtypes during a positive mood induction: Predicting clinical response in a randomized controlled trial of ketamine for treatment-resistant depressionShabnam Hossein, Mary L Woody, Benjamin Panny, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 30, 2007
Neoadjuvant chemotherapy in locally advanced primary breast cancers: the Nottingham experienceJ Mathew, K S Asgeirsson, A Agrawal, et al.
Nature Communications|May 15, 2015
Muscle stem cells contribute to myofibres in sedentary adult miceAlexandra C Keefe, Jennifer A Lawson, Steven D Flygare, et al.
Heart Rhythm O2|September 13, 2022
Conduction system pacing versus conventional pacing in patients undergoing atrioventricular node ablation: Nonrandomized, on-treatment comparisonPugazhendhi Vijayaraman, Andrew J Mathew, Angela Naperkowski, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 19, 2023
Neural complexity EEG biomarkers of rapid and post-rapid ketamine effects in late-life treatment-resistant depression: a randomized control trialNicholas Murphy, Amanda J F Tamman, Marijn Lijffijt, et al.
Contemporary Clinical Trials Communications|September 12, 2019
Bayesian adaptive randomization trial of intravenous ketamine for veterans with late-life, treatment-resistant depressionBrittany O'Brien, Charles E Green, Rayan Al-Jurdi, et al.
Clinical Genetics|April 4, 2017
Clinical genetic testing in pediatric cardiomyopathy: Is bigger better?A C Ouellette, J Mathew, A K Manickaraj, et al.
Journal of Neurosurgery. Case Lessons|September 11, 2022
Detection of perillyl alcohol and its metabolite perillic acid in postsurgical glioblastoma tissue after intranasal administration of NEO100: illustrative caseAxel H Schönthal, Steve Swenson, Phillip A Bonney, et al.
American Journal of Surgery|August 8, 2018
The burden of excess length of stay in trauma patientsPrakash J Mathew, Faisal Jehan, Narong Kulvatunyou, et al.
Pageof 85

Showing results (621-630 of 845) with videos related to

Sort By:
Pageof 85
JAMA Psychiatry|March 2, 2017
A Consensus Statement on the Use of Ketamine in the Treatment of Mood DisordersGerard Sanacora, Mark A Frye, William McDonald, et al.
Journal of Psychopathology and Clinical Science|September 23, 2024
Functional connectivity subtypes during a positive mood induction: Predicting clinical response in a randomized controlled trial of ketamine for treatment-resistant depressionShabnam Hossein, Mary L Woody, Benjamin Panny, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 30, 2007
Neoadjuvant chemotherapy in locally advanced primary breast cancers: the Nottingham experienceJ Mathew, K S Asgeirsson, A Agrawal, et al.
Nature Communications|May 15, 2015
Muscle stem cells contribute to myofibres in sedentary adult miceAlexandra C Keefe, Jennifer A Lawson, Steven D Flygare, et al.
Heart Rhythm O2|September 13, 2022
Conduction system pacing versus conventional pacing in patients undergoing atrioventricular node ablation: Nonrandomized, on-treatment comparisonPugazhendhi Vijayaraman, Andrew J Mathew, Angela Naperkowski, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 19, 2023
Neural complexity EEG biomarkers of rapid and post-rapid ketamine effects in late-life treatment-resistant depression: a randomized control trialNicholas Murphy, Amanda J F Tamman, Marijn Lijffijt, et al.
Contemporary Clinical Trials Communications|September 12, 2019
Bayesian adaptive randomization trial of intravenous ketamine for veterans with late-life, treatment-resistant depressionBrittany O'Brien, Charles E Green, Rayan Al-Jurdi, et al.
Clinical Genetics|April 4, 2017
Clinical genetic testing in pediatric cardiomyopathy: Is bigger better?A C Ouellette, J Mathew, A K Manickaraj, et al.
Journal of Neurosurgery. Case Lessons|September 11, 2022
Detection of perillyl alcohol and its metabolite perillic acid in postsurgical glioblastoma tissue after intranasal administration of NEO100: illustrative caseAxel H Schönthal, Steve Swenson, Phillip A Bonney, et al.
American Journal of Surgery|August 8, 2018
The burden of excess length of stay in trauma patientsPrakash J Mathew, Faisal Jehan, Narong Kulvatunyou, et al.
Pageof 85